You may have heard in the past that CVS had started to pull Zantac from the shelves over Cancer concerns. Now Sanofi has announced they are pulling the widely used heart burn medication Zantac from stores all over the United States and Canada. They’ve decided to do this to investigate a probable carcinogen detected in the drug.
The FDA said that it discovered a probable carcinogen called NDMA in the drug Zantac and its generic versions. They, along with Canadian and European drug regulators, are testing the possible risk to millions of people who take ranitidine, the main active ingredient in Zantac medications.